120 completed, 36 unknown, 21 terminated, 18 recruiting. 220 Phase 2, 69 Phase 1, 31 Phase 3.
Follow Spinal Cord Injuries: new trials by email Literature Review of Spinal Cord Injuries trials Research Report on Spinal Cord Injuries
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Device for Bladder Control for Men With SCI Noninvasive electrical stimulation device to improve bladder control - Neurogenic Bladder | Phase 1 / Phase 2 | Not yet recruiting | VA Office of Research and Development | 12 | 2028-06-01 | 2026-06-25 |
| Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial Allogeneic Human Induced Pluripotent Stem Cell (iPSC)-Derived Motor Neuron Progenitor Cells, Placebo - Spinal Cord Injury, Safety | Phase 2 | Not yet recruiting | XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | 60 | 2028-05-25 | 2025-11-25 |
| Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial testosterone cypionate, finasteride, placebo injection - Spinal Cord Injury, Spinal Cord Injuries | Phase 2 / Phase 3 | Not yet recruiting | VA Office of Research and Development | 300 | 2027-10-01 | 2026-08-04 |
| Combining Low Oxygen Therapy and an Adenosine A2a Receptor Antagonist to Improve Functional Mobility After Spinal Cord Injury Istradefylline, low oxygen therapy - Spinal Cord Injuries, Myelopathy | Phase 1 / Phase 2 | Not yet recruiting | Randy Trumbower, PT, PhD | 40 | 2027-09-01 | 2026-03-20 |
| NO AD: Use of Nitric Oxide (NO) Donors for the Prevention of Autonomic Dysreflexia (AD) During Bowel Care Following SCI Glyceryl Trinitrate Only Product in Oromucosal Dose Form, Placebo sublingual spray - Spinal Cord Injuries, Autonomic Dysreflexia | Phase 2 | Not yet recruiting | Simon Fraser University | 26 | 2026-12-01 | 2026-04-23 |
| Pilot Testing of Vagus Nerve Stimulation for Early Spinal Cord Injury Recovery Transauricular vagus nerve stimulation - Spinal Cord Injuries (Complete and Incomplete) | Phase 1 / Phase 2 | Not yet recruiting | University of Alabama at Birmingham | 50 | 2026-11-01 | 2026-08-05 |
| Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI) Galantamine Hydrobromide Extended Release - Spinal Cord Injury, Traumatic Spinal Cord Injury | Phase 2 / Phase 3 | Recruiting | Northwell Health | 60 | 2026-10-15 | 2026-11-04 |
| Extracorporeal Shockwave Therapy as an Additional Treatment for Spasticity Secondary to Spinal Cord Injury Focused extracorporeal shockwave therapy, Botulinum toxin, Sham - Spinal Cord Injury, Spasticity | Phase 2 | Recruiting | Kessler Foundation | 30 | 2026-09-21 | 2026-11-04 |
| Psilocybin to Treat Depression in Spinal Cord Injury Psilocybin (Usona Institute) - Spinal Cord Injury, Depression - Major Depressive Disorder | Phase 1 / Phase 2 | Recruiting | James J. Peters Veterans Affairs Medical Center | 30 | 2026-08-06 | 2026-08-10 |
| Long-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Gene Therapy Urodynamics, EG110A, Patient-reported Outcome - Urinary Bladder, Overactive, Spinal Cord Injury | Phase 1 / Phase 2 | Not yet recruiting | Cyllene Therapeutics | 16 | 2026-04-01 | 2025-11-12 |
| CE-STAND: Cervical Epidural STimulation After Neurologic Damage Epidural Spinal Cord Stimulation System - Spinal Cord Injury | Phase 1 / Phase 2 | Recruiting | University of Minnesota | 36 | 2026-03-15 | 2026-03-27 |
| CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury CBD - Supra-sacral Spinal Cord Injury, Spinal Cord Injury | Phase 2 | Recruiting | University of Wisconsin, Madison | 20 | 2026-02-13 | 2026-09-16 |
| Improving Walking After Spinal Cord Injury Paired Associative Stimulation, Locomotor Training, Sham stimulation - Spinal Cord Injury | Phase 1 / Phase 2 | Not yet recruiting | Shirley Ryan AbilityLab | 20 | 2025-11-15 | 2025-11-03 |
| Improving 24-hour Blood Pressure Stability in Spinal Cord Injury With Low Oxygen Therapy Low oxygen therapy (LOT) - Spinal Cord Injury | Phase 1 / Phase 2 | Recruiting | Glen Foster | 10 | 2025-10-23 | 2025-11-18 |
| Guttmann NeuroRecovery - Viability, Safety, and Efficacy of Intrathecal Wharton's Jelly Mesenchymal Stem Cells and Transcutaneous Spinal Cord Stimulation in Chronic Spinal Cord Injury Rehabilitation Allogeneic Wharton's jelly mesenchymal stem cells (WJ-MSCs) - Spinal Cord Injuries (SCI), Spinal Cord Injury | Phase 1 / Phase 2 | Not yet recruiting | Institut Guttmann | 10 | 2025-09-01 | 2025-05-25 |
| Paired Stimulation Plasticity for Motor Recovery in Humans With and Without Spinal Cord Injury CST PAS, RST PAS, sham PAS - Healthy Control, Spinal Cord Injury | Phase 2 | Recruiting | Shirley Ryan AbilityLab | 300 | 2025-08-28 | 2026-10-14 |
| First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury STUP-001 - Spinal Cord Injury, Chronic Spinal Cord Injury | Phase 1 / Phase 2 | Recruiting | Yonsei University | 9 | 2025-07-30 | 2025-07-16 |
| Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCI CBD/CBD-A, Placebo - SCI - Spinal Cord Injury, Neuropathic Pain | Phase 1 / Phase 2 | Completed | University of Miami | 6 | 2025-06-16 | 2026-08-14 |
| Double Dose 4-AP on Functional Recovery After Spinal Cord Injury Dalfampridine, Placebo, STDP stimulation - SCI - Spinal Cord Injury | Phase 1 / Phase 2 | Recruiting | Shirley Ryan AbilityLab | 27 | 2025-02-01 | 2026-06-03 |
| Treating Central Neuropathic Pain With Low Dose Naltrexone for People With Spinal Cord Injury 4.5mg daily dose of naltrexone - Central Neuropathic Pain, Spinal Cord Injury | Phase 2 | Completed | Medical College of Wisconsin | 11 | 2025-02-01 | 2026-11-02 |
Showing 20 of 220. Sign in to see all of them.
Quadriplegia (19) · Paraplegia (14) · Spinal Cord Diseases (12) · Urinary Bladder, Neurogenic (10) · Wounds and Injuries (10) · Neuralgia (9) · Osteoporosis (8) · Bone Diseases, Metabolic (6) · Central Nervous System Diseases (6) · Chronic Pain (6) · Nervous System Diseases (6) · Neurologic Manifestations (6) · Paralysis (6) · Agnosia (5)
Central Nervous System Diseases (214) · Nervous System Diseases (214) · Trauma, Nervous System (213) · Wounds and Injuries (210) · Spinal Cord Diseases (208) · Pathological Conditions, Signs and Symptoms (80) · Signs and Symptoms (76) · Neurologic Manifestations (57) · Male Urogenital Diseases (21) · Urogenital Diseases (21) · Female Urogenital Diseases (19) · Female Urogenital Diseases and Pregnancy Complications (19) · Urologic Diseases (19) · Paralysis (18) · Pain (15)
Sodium Chloride (6) · Botulinum Toxins, Type A (4) · Buspirone (4) · Lithium Carbonate (4) · Midodrine (4) · Resistance Training (4) · Cholecalciferol (3) · Methylprednisolone (3) · NG-Nitroarginine Methyl Ester (3) · Transcranial Direct Current Stimulation (3) · Vitamin D (3) · mirabegron (3) · salicylhydroxamic acid (3) · 4-Aminopyridine (2) · Alendronate (2)
US Department of Veterans Affairs (13) · VA Office of Research and Development (13) · Kessler Foundation (8) · James J. Peters Veterans Affairs Medical Center (7) · China Spinal Cord Injury Network (5) · Brigham and Women's Hospital (4) · Medstar Health Research Institute (4) · Northwestern University (4) · Shirley Ryan AbilityLab (4) · Spaulding Rehabilitation Hospital (4) · University of Alberta (4) · University of British Columbia (4) · Chinese Academy of Sciences (3) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (3) · Hugo W. Moser Research Institute at Kennedy Krieger, Inc. (3)
United States (129) · Canada (24) · China (17) · Spain (12) · South Korea (7) · Switzerland (6) · Australia (5) · India (5) · Japan (4) · Germany (3) · Jordan (3) · Russia (3) · Taiwan (3) · Brazil (2) · Denmark (2)
Nancy Rocheleau, Program Analyst (5) · Thomas J Schnitzer, MD, PhD (5) · John Fryer, Ph.D. Asst. Director (4) · Ashraf Gorgey, PhD PT (3) · Jessica D'Amico, PhD (3) · Limin Rong, M.D. (3) · Trevor A. Dyson-Hudson, M.D. (3) · William Bauman, MD (3) · Antonio Oliviero, MD, PhD (2) · Ashraf S Gorgey, PhD (2) · Christine N. Sang, MD, MPH (2) · Cornelia Haag-Molkenteller, MD (2) · Cristina L Sadowsky, MD (2) · Hui Zhu, MD (2) · Jeanne M Zanca, PhD, MPT (2)
PMID 21762873, PMID 30334093, PMID 36875669, PMID 10569435, PMID 15663976, PMID 16398945, PMID 16793729, PMID 17046161, PMID 17385265, PMID 17475549, PMID 17965289, PMID 19618698, PMID 19648013, PMID 19651280, PMID 19799783, PMID 19903102, PMID 19996767, PMID 20012982, PMID 20418657, PMID 20801263, PMID 21252493, PMID 21303266, PMID 21372246, PMID 21381984, PMID 21717386, PMID 21949432, PMID 22105463, PMID 22232031, PMID 22505632, PMID 22525310, PMID 22985379, PMID 23295632, PMID 23343764, PMID 23452836, PMID 23532434, PMID 23700789, PMID 23844986, PMID 24401143, PMID 24824524, PMID 24968251, PMID 24987412, PMID 25209445, PMID 26394202, PMID 26705884, PMID 26828618, PMID 27901413, PMID 28864949, PMID 28948164, PMID 29244816, PMID 30467135
2016 (2), R01NS041503 (2), 1IK2CX000547 (1), 2014 (1), 2018 (1), 2019 (1), 2025 (1), I01RX001449 (1), I01RX003415 (1), I21RX004417 (1), P30CA016672 (1), R01DA030424 (1), R01HD081274 (1), R01HD093724 (1), R01HD103904 (1)